SCHEMBL4894296

SCHEMBL4894296

O=C(NCCC12CC3CC(CC(C3)C1)C2)c1c(Cl)ccc2nc(Cl)ccc12

nearest known ligand 0.55

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 19/20 0.55
EPHX2 P34913 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4497262 0.89 P2RX7 (0.68) P2RX7
SCHEMBL4888456 0.83 P2RX7 (0.61) P2RX7
SCHEMBL4888579 0.81 P2RX7 (0.60) P2RX7
SCHEMBL4511013 0.78 P2RX7 (0.66) P2RX7EPHX2
SCHEMBL4508282 0.77 P2RX7 (0.65) P2RX7
SCHEMBL14113747 0.77 P2RX7 (0.55) P2RX7
SCHEMBL4508092 0.76 P2RX7 (0.62) P2RX7
SCHEMBL4896407 0.76 P2RX7 (0.64) P2RX7
SCHEMBL3839490 0.76 P2RX7 (0.55) P2RX7
SCHEMBL4508087 0.75 P2RX7 (0.61) P2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080182874-A1 Novel Compounds ASTRAZENECA AB (SE) 2008-07-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080182874-A1 Novel Compounds REN, F12, GPR119 P2RX7 1672/4885EPHX2 1030/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.